Market Access, Pricing & Reimbursement Global Congress 2017 Americas

The two-day Market Access, Pricing and Reimbursement Global Congress 2017 Americas will provide a unique platform and a dynamic approach to key trends, methodologies and insights on market access, real world data, pricing, reimbursement, patient access and data collection than the current industry standard is anticipated.

Gain Latest Insights On:

Strategies for one of pharma industry’s greatest challenge: market access
Health Technology Assessment in Health-Care
Real word evidence and randomised control trials, close the gap
Growth of biosimilars and importance of RWE for orphan drugs and rare diseases
Emerging markets: the impact on global pricing and commercialization
Challenges and opportunities in pricing, reimbursement and patient access
Risk sharing agreements, benefits and challenges
Looking to the future: what to expect?

Who you will meet: Members of Boards, Vice President’s, Directors, Head/Chief and Senior Managers from the pharma industry involved in:

Market Access
Pricing and Reimbursement
Patient Outcomes
Health Economics and Outcomes Research
Payer Relations/ Evidence
Data Management/ Analysis
Regulatory Affairs
Public/ Government Affairs
Payers
HTA Officials
Physicians